## 
## Industry Non-Peer Reviewed                        NCl 
##                         10                          5 
##                        NIH               Other - Peer 
##                         78                         10 
##             Other Non-Peer            Training Grants 
##                          8                         13

Per-grant graphs

NIH

Industry Non-Peer Reviewed

NCl

Training Grants

Other - Peer

Other Non-Peer

## 
## 
## ### All Grants — Keyword Summary
keyword total_count Type Grant
neoplasm 55 Primary NIH
biomarker 37 Secondary NIH
malignancy 30 Primary NIH
stem cell 25 Primary NIH
oncology 24 Primary NIH
prevention 23 Secondary NIH
immunotherapy 20 Primary NIH
tumor 20 Primary NIH
cancer 19 Primary NIH
drug delivery 17 Secondary NIH
epigenetic 11 Primary NIH
mutation 11 Primary NIH
transcriptional regulation 11 Primary NIH
signal transduction 10 Primary NIH
obesity 10 Secondary NIH
rural 10 Secondary NIH
screening 9 Secondary NIH
cell differentiation 8 Primary NIH
dna damage 8 Primary NIH
carcinoma 7 Primary NIH
cell proliferation 7 Primary NIH
clinical trial phase i 7 Secondary NIH
chromatin organization 6 Primary NIH
drug development 6 Secondary NIH
risk factor 6 Secondary NIH
cell death 5 Primary NIH
drug discovery 5 Primary NIH
radiation 5 Primary NIH
experimental therapeutics 4 Primary NIH
apoptosis 3 Primary NIH
dna repair 3 Primary NIH
oncogene 3 Primary NIH
clinical trial phase ii 3 Secondary NIH
clinical trial phase iii 3 Secondary NIH
blastoma 2 Primary NIH
chemo 2 Primary NIH
chemotherapy 2 Primary NIH
glioma 2 Primary NIH
lymphoma 2 Primary NIH
melanoma 2 Primary NIH
myeloma 2 Primary NIH
radiotherapy 2 Primary NIH
sarcoma 2 Primary NIH
exercise 2 Secondary NIH
hepatitis 2 Secondary NIH
leukemia 1 Primary NIH
lung 1 Primary NIH
smoking 1 Primary NIH
tobacco 1 Primary NIH
alcohol 1 Secondary NIH
neoplasm 6 Primary Industry Non-Peer Reviewed
carcinoma 4 Primary Industry Non-Peer Reviewed
breast 2 Primary Industry Non-Peer Reviewed
cancer 2 Primary Industry Non-Peer Reviewed
lung 2 Primary Industry Non-Peer Reviewed
malignancy 1 Primary Industry Non-Peer Reviewed
prostate 1 Primary Industry Non-Peer Reviewed
cancer 5 Primary NCl
neoplasm 3 Primary NCl
oncology 3 Primary NCl
clinical trial phase i 3 Secondary NCl
clinical trial phase ii 3 Secondary NCl
clinical trial phase iii 3 Secondary NCl
apoptosis 2 Primary NCl
dna repair 2 Primary NCl
prevention 2 Secondary NCl
breast 1 Primary NCl
carcinoma 1 Primary NCl
colorectal 1 Primary NCl
dna damage 1 Primary NCl
experimental therapeutics 1 Primary NCl
immunotherapy 1 Primary NCl
lung 1 Primary NCl
lymphoma 1 Primary NCl
malignancy 1 Primary NCl
metastatic 1 Primary NCl
mutation 1 Primary NCl
radiation 1 Primary NCl
radiotherapy 1 Primary NCl
survivorship 1 Primary NCl
tumor 1 Primary NCl
biomarker 1 Secondary NCl
drug development 1 Secondary NCl
risk factor 1 Secondary NCl
rural 1 Secondary NCl
screening 1 Secondary NCl
cancer 2 Primary Training Grants
neoplasm 2 Primary Training Grants
clinical trial phase i 2 Secondary Training Grants
obesity 2 Secondary Training Grants
chromatin organization 1 Primary Training Grants
dna damage 1 Primary Training Grants
dna repair 1 Primary Training Grants
immunotherapy 1 Primary Training Grants
leukemia 1 Primary Training Grants
lymphoma 1 Primary Training Grants
malignancy 1 Primary Training Grants
mutation 1 Primary Training Grants
oncology 1 Primary Training Grants
survivorship 1 Primary Training Grants
drug development 1 Secondary Training Grants
exercise 1 Secondary Training Grants
prevention 1 Secondary Training Grants
cancer 4 Primary Other - Peer
carcinoma 4 Primary Other - Peer
signal transduction 3 Primary Other - Peer
tumor 3 Primary Other - Peer
exercise 3 Secondary Other - Peer
risk factor 3 Secondary Other - Peer
colorectal 2 Primary Other - Peer
experimental therapeutics 2 Primary Other - Peer
metastatic 2 Primary Other - Peer
biomarker 2 Secondary Other - Peer
drug development 2 Secondary Other - Peer
obesity 2 Secondary Other - Peer
prevention 2 Secondary Other - Peer
apoptosis 1 Primary Other - Peer
breast 1 Primary Other - Peer
cell differentiation 1 Primary Other - Peer
cell proliferation 1 Primary Other - Peer
chemotherapy 1 Primary Other - Peer
chromatin organization 1 Primary Other - Peer
drug discovery 1 Primary Other - Peer
immunotherapy 1 Primary Other - Peer
malignancy 1 Primary Other - Peer
mutation 1 Primary Other - Peer
neoplasm 1 Primary Other - Peer
p53 1 Primary Other - Peer
stem cell 1 Primary Other - Peer
cirrhosis 1 Secondary Other - Peer
clinical trial phase i 1 Secondary Other - Peer
rural 1 Secondary Other - Peer
cancer 2 Primary Other Non-Peer
mutation 2 Primary Other Non-Peer
risk factor 2 Secondary Other Non-Peer
apoptosis 1 Primary Other Non-Peer
carcinoma 1 Primary Other Non-Peer
dna damage 1 Primary Other Non-Peer
immunotherapy 1 Primary Other Non-Peer
malignancy 1 Primary Other Non-Peer
neoplasia 1 Primary Other Non-Peer
neoplasm 1 Primary Other Non-Peer
oncology 1 Primary Other Non-Peer
stem cell 1 Primary Other Non-Peer
biomarker 1 Secondary Other Non-Peer
cirrhosis 1 Secondary Other Non-Peer
clinical trial phase i 1 Secondary Other Non-Peer
clinical trial phase ii 1 Secondary Other Non-Peer
clinical trial phase iii 1 Secondary Other Non-Peer
obesity 1 Secondary Other Non-Peer
prevention 1 Secondary Other Non-Peer
rural 1 Secondary Other Non-Peer
screening 1 Secondary Other Non-Peer
vaccine 1 Secondary Other Non-Peer 
## 
## 
## ### All Grants — Record Detail
Number Title URL Grant Primary_Keywords Secondary_Keywords Total_Matches
D9341C00001 A Long-term Follow-up Master Protocol for Participants who Received Cell or Gene Therapies in Other AstraZeneca Studies (LOCUS) https://clinicaltrials.gov/study/NCT06194461 Industry Non-Peer Reviewed carcinoma, cancer, neoplasm, prostate 5
FLEX Study MammaPrint BluePrint and Full-genome Data Linked with Clinical Data to Evaluate New Gene EXpression Profiles: An Adaptable Registry Study Details | NCT03053193 | MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles | ClinicalTrials.gov Industry Non-Peer Reviewed breast, cancer, neoplasm 4
EG-70-101 A Phase I/II Study of EG-70 as an Intravesical Administration to Patients with BCG-Unresponsive NMIBC and High-Risk NMIBC Patients who are BCG Na�ve or Received Incomplete BCG Treatment (LEGEND STUDY) Study Details | NCT04752722 | LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve | ClinicalTrials.gov Industry Non-Peer Reviewed neoplasm, carcinoma, lung 3
IIT-2020-CAFs CAFs (Combination of Atezolizumab and pirfenidone in Second-line and Beyond NSCLC): a Phase I/II study Study Details | NCT04467723 | Combination of Atezolizumab and Pirfenidone in Second-line and Beyond NSCLC | ClinicalTrials.gov Industry Non-Peer Reviewed neoplasm, carcinoma, lung 3
KT-US-982-5968 Long-Term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated with Gene-Modified Cells Study Details | NCT05041309 | Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified Cells | ClinicalTrials.gov Industry Non-Peer Reviewed neoplasm, malignancy 2
MPN-RC-106 MPN-RC Research Tissue Bank Research Tissue Bank (Myeloproliferative Neoplasms Research Consortium [MPN-RC] 106) | Cleveland Clinic Industry Non-Peer Reviewed neoplasm 1
UG1CA233277 National Clinical Trials Network Research at the University of Wisconsin https://reporter.nih.gov/search/cawnLFaRJkipL7bxce0vIA/project-details/10999695#similar-Projects NCl cancer, oncology, neoplasm, metastatic, lymphoma, radiation, radiotherapy clinical trial phase i, clinical trial phase ii, clinical trial phase iii, prevention 11
5R01CA284633-02 Ribonucleotide Processing in Telomere Maintenance and Integrity https://reporter.nih.gov/search/SUD_G-cOjEyt_wz72UT7Yw/project-details/11072066#similar-Projects NCl dna repair, apoptosis, cancer, malignancy, carcinoma, dna damage, mutation risk factor 10
5U01CA290664-02 KanSurvive 2.0 https://reporter.nih.gov/search/oRBnrLkSW0ucIWZB7fAGQQ/project-details/11134671#similar-Projects NCl cancer, oncology, neoplasm, breast, lung, colorectal, survivorship screening, rural 9
3U10CA180888-11S2 SWOG Network Group Operations Center of the NCTN https://reporter.nih.gov/search/uMk7U8AgZEa9QB1hlsbchA/project-details/11251678#similar-Projects NCl cancer, oncology, neoplasm, immunotherapy clinical trial phase i, clinical trial phase ii, clinical trial phase iii, drug development 8
5R50CA290098-02 Increasing Access and Participation to Early Phase Clinical Trials https://reporter.nih.gov/search/5PbxumbntUu5LPKwCDwJLA/project-details/11163214 NCl cancer, tumor, experimental therapeutics clinical trial phase i, clinical trial phase ii, clinical trial phase iii, prevention, biomarker 8
5R01HL148463-07 Characterization of Sedentary Patterns and Cardiovascular Disease Risk Markers in Hispanics/Latinos https://reporter.nih.gov/search/7Qv7S93ldkSTg_5_SfEkOA/project-details/10657447#similar-Projects NIH neoplasm, tumor, oncology, chemo, chemotherapy, malignancy, carcinoma, leukemia, melanoma, sarcoma, lymphoma, blastoma, glioma, dna damage, dna repair, mutation, stem cell, radiation, radiotherapy, immunotherapy, signal transduction, transcriptional regulation, oncogene, cell proliferation, cell differentiation, cell death, apoptosis, chromatin organization, epigenetic, drug discovery, experimental therapeutics, myeloma clinical trial phase i, clinical trial phase ii, clinical trial phase iii, screening, prevention, drug delivery, drug development, biomarker, risk factor 42
5R01HD105714-05 REST/NRSF, miRNAs, and Tissue Remodeling in Adenomyosis Pathophysiology https://reporter.nih.gov/search/ZwDtWFcbCE2E0IuiWacyng/project-details/10277800#similar-Projects NIH neoplasm, tumor, oncology, chemo, chemotherapy, malignancy, carcinoma, melanoma, sarcoma, lymphoma, blastoma, glioma, dna damage, dna repair, mutation, stem cell, radiation, radiotherapy, immunotherapy, signal transduction, transcriptional regulation, oncogene, cell proliferation, cell differentiation, cell death, apoptosis, chromatin organization, epigenetic, drug discovery, experimental therapeutics, myeloma clinical trial phase i, clinical trial phase ii, clinical trial phase iii, screening, prevention, drug delivery, drug development, biomarker, risk factor 41
5P01AI162242-05 Impact of Antibody Effector Function Diversity on Antiviral Activity In Situ https://reporter.nih.gov/search/AM2Udhpv_EmcoeERM1VUqg/project-details/10670229#similar-Projects NIH neoplasm, tumor, oncology, malignancy, carcinoma, stem cell, immunotherapy, signal transduction, transcriptional regulation, oncogene, cell proliferation, cell differentiation, cell death, apoptosis, chromatin organization, epigenetic, drug discovery, experimental therapeutics clinical trial phase i, clinical trial phase ii, clinical trial phase iii, screening, prevention, drug delivery, drug development, biomarker, risk factor 28
5P41EB020594-11 Biotechnology Resource Center of BioModular Multi-scale Systems (CBM2) for Precision Medicine: Single-Molecule Processing: Detection and Identification of Single DNAs, RNAs, and Proteins using Immobilized Nanoscale Enzymatic Reactors (INERs) and Nanoscale Electrophoresis https://reporter.nih.gov/search/79mIRXh520-c_C6K0WM1sA/project-details/11141029#similar-Projects NIH neoplasm, cancer, tumor, malignancy, carcinoma, dna damage, mutation, epigenetic screening, biomarker 11
1R21EB035809-01A1 In-vivo Characterization of White Adipose Tissue with Quantitative Ultrasound https://reporter.nih.gov/project-details/11056465 NIH neoplasm, tumor, oncology, malignancy, stem cell, immunotherapy prevention, drug delivery, biomarker 10
5P20GM139733-03 Kansas Center for Implementation Science: Nutricity: A mHealth nutrition intervention to improve diet quality among children https://reporter.nih.gov/search/TKLWBqat0UaDRNpiLW2lzQ/project-details/11180214#similar-Projects NIH neoplasm, oncology, malignancy, stem cell, immunotherapy prevention, obesity, drug delivery, biomarker 10
5R01HD105714-05 REST/NRSF, miRNAs, and Tissue Remodeling in Adenomyosis Pathophysiology https://reporter.nih.gov/search/W82vxCTeVkGSOl1QYFTpDQ/project-details/11085179 NIH neoplasm, tumor, oncology, malignancy, stem cell, immunotherapy prevention, drug delivery, biomarker 10
5R01HD110447-03 Systematic Identification and Phenotypic Characterization of causal genetic variants in Rare Disease-Associated Birth Defects https://reporter.nih.gov/search/FFv-S9qaJk2Syh1J1q5AMw/project-details/10992638 NIH neoplasm, tumor, oncology, malignancy, stem cell, immunotherapy prevention, drug delivery, biomarker 10
5R01NR019810-04 iAmHealthy Parents First https://reporter.nih.gov/search/cmRjTTYUL0On1nGWM4nHkA/project-details/11004150 NIH neoplasm, tumor, oncology, malignancy, stem cell, immunotherapy prevention, drug delivery, biomarker 10
5R21AI181336-02 Role of ICP0 Dimerization in Herpes Simplex Virus Pathogenesis https://reporter.nih.gov/search/QED9xQgHTkWhk1dHYyj8OA/project-details/11126079 NIH neoplasm, tumor, oncology, malignancy, stem cell, immunotherapy prevention, drug delivery, biomarker 10
5R21HD110932-02 Circular RNA Role in Ovarian Follicular Development and Fertility https://reporter.nih.gov/search/A2A6ja23B0aqOLpegujEwg/project-details/11175268 NIH neoplasm, tumor, oncology, malignancy, stem cell, immunotherapy prevention, drug delivery, biomarker 10
5R35GM147169-04 New catalytic strategies to make non-proteinogenic peptides https://reporter.nih.gov/search/gbjanCK0m0qHDReMbD-HdQ/project-details/11086619 NIH neoplasm, tumor, oncology, malignancy, stem cell, immunotherapy prevention, drug delivery, biomarker 10
5P41EB020594-11 Biotechnology Resource Center of BioModular Multi-scale Systems (CBM2) for Precision Medicine: Manufacture and Assembly of Thermoplastic, Modular, Integrated Fluidic Systems https://reporter.nih.gov/search/79mIRXh520-c_C6K0WM1sA/project-details/11141036#similar-Projects NIH neoplasm, cancer, tumor, malignancy, dna damage, mutation screening, biomarker 9
5R01AG069781-05 Ketogenic oscillations and neurometabolic healthspan https://reporter.nih.gov/search/2SH-4dHfZ0Km64Ludh6rLQ/project-details/10849833 NIH neoplasm, tumor, oncology, malignancy, stem cell, immunotherapy prevention, biomarker 9
5R01DK126456-04 Beta-cell responses to oxidative stress and Type 1 diabetes https://reporter.nih.gov/search/CLclQ9XPz0aLN7XvfDseFA/project-details/10860959 NIH neoplasm, tumor, oncology, malignancy, immunotherapy prevention, drug delivery, biomarker 9
5R01ES030994-06 SOLAir: Environmental Factors and Diabetes Development in Latinos https://reporter.nih.gov/search/tuxf6uyNeUS5O4AgNmLKUw/project-details/11171457 NIH neoplasm, oncology, malignancy, stem cell, immunotherapy prevention, drug delivery, biomarker 9
5R01ES034410-03 Interaction between Genome and Heavy Metals in Nonalcoholic Fatty Liver Disease https://reporter.nih.gov/search/JGPJeQN_wkqNV2SofoRxwQ/project-details/11128507 NIH neoplasm, malignancy, transcriptional regulation, drug discovery prevention, obesity, biomarker, risk factor, alcohol 9
5R01HL168535-02 Leveraging deep learning to classify sitting posture and measure sedentary patterns from accelerometer data in diverse cohorts https://reporter.nih.gov/search/6A94ypi2OketJviCgKH6bg/project-details/10997425 NIH neoplasm, tumor, oncology, malignancy, stem cell, immunotherapy prevention, biomarker 9
1R21AI188180-01A1 Determining the role of PARP14 in restricting HSV-1 replication https://reporter.nih.gov/search/htNuIyRKrEGzy4vH6Zbv4g/project-details/11234037 NIH neoplasm, oncology, malignancy, stem cell, immunotherapy drug delivery, biomarker 8
5P41EB020594-11 Biotechnology Resource Center of BioModular Multi-scale Systems (CBM2) for Precision Medicine https://reporter.nih.gov/search/-qWu4LpuYEeNsYVIT48KMQ/project-details/11141025 NIH cancer, tumor, neoplasm, dna damage, mutation, epigenetic screening, biomarker 8
5P41EB020594-11 Biotechnology Resource Center of BioModular Multi-scale Systems (CBM2) for Precision Medicine: Facilitating a Multi-Institutional Enterprise https://reporter.nih.gov/search/79mIRXh520-c_C6K0WM1sA/project-details/11141026#similar-Projects NIH cancer, tumor, neoplasm, dna damage, mutation, epigenetic screening, biomarker 8
5R01DK131716-03 Islet encapsulation to elicit localized immunosuppression and immune modulation following transplantation https://reporter.nih.gov/search/bXbDsBFXcUGDndpcXj4wGA/project-details/11158811 NIH neoplasm, tumor, oncology, malignancy, stem cell, immunotherapy biomarker 8
5R01DK132350-04 Health Impacts of City-Wide Zero-Fare Bus Transit: A Natural Experiment https://reporter.nih.gov/search/tsLd9CtAakKCWFqIPfwiNw/project-details/11014442 NIH neoplasm, oncology, malignancy, stem cell, immunotherapy drug delivery, biomarker 8
5R01NR021468-02 Addressing Malnutrition in Transplant and Cellular Therapy Patients with Healthcare-Food Bank Partnerships https://reporter.nih.gov/search/rbCLtefeAkK8zh9VCRR-7Q/project-details/11195727#similar-Projects NIH cancer, oncology, neoplasm, malignancy 8
5R21AI178204-02 The role of C/EBPß in sepsis associated acute-on-chronic liver failure https://reporter.nih.gov/search/C2xM4oQbU0-eBzbi49lmDg/project-details/11134516 NIH neoplasm, oncology, malignancy, stem cell, immunotherapy drug delivery, biomarker 8
5P20GM152280-02 Leveraging Big Data to Improve Women’s Health (BD-WH) https://reporter.nih.gov/search/7JjE2ZPXhkenEkWKePJGyg/project-details/11074609#similar-Projects NIH cancer, tumor, oncology, neoplasm, malignancy biomarker 7
5R00ES033771-04 Investigating the Cellular Impact of 8-oxo-Guanine on DNA Replication and Genome Stability https://reporter.nih.gov/search/5bJoORVMvk-lAT58C2bhSw/project-details/10977080 NIH cancer, carcinoma, dna damage, mutation, radiation, cell death, smoking 7
5R01DK138469-02 Uncovering the Interplay Among Pancreatic Tissue Types, Inflammation, and Genotypes in Type 1 Diabetes https://reporter.nih.gov/search/M2Uc5ZWUA0OdgQYgBPHr0A/project-details/11005395 NIH neoplasm, oncology, malignancy, stem cell, immunotherapy biomarker 7
1R21AI194021-01  Phosphoglycerate mutase 5 a mitochondrial serin/threonine phosphatase a novel target to mitigate GI-ARS. https://reporter.nih.gov/project-details/11224659 NIH stem cell, radiation, signal transduction, transcriptional regulation, cell proliferation prevention 6
3P20GM152280-02S1 Understanding the role of cholesterol and the female sex hormone, estrogen, on the mechanical properties of model myelin membranes https://reporter.nih.gov/search/EQhCjlicNUiD3oEmS4kikg/project-details/11219126#similar-Projects NIH cancer, neoplasm, malignancy rural, biomarker, risk factor 6
5P20GM139733-03 Kansas Center for Implementation Science https://reporter.nih.gov/search/7k2fFSnVfkabXCD6a2wLVw/project-details/11180158 NIH cancer, lung, tobacco clinical trial phase i, prevention, rural 6
5R01DK134737-03 Mechanisms Regulating Lipoprotein Secretion And Lipid Metabolism https://reporter.nih.gov/search/cLwJFS1s5kS5ZSKrWQniOg/project-details/10997361 NIH cell death, drug discovery obesity, prevention, biomarker 6
5R21AI182029-02 Characterization of 5’-human-HBV-3’ RNA species transcribed from integrated HBV DNA https://reporter.nih.gov/search/w3Xo4_SmnUS7BppR5QTvgg/project-details/11017777 NIH cancer, carcinoma, dna repair, transcriptional regulation biomarker, hepatitis 6
5R35GM146966-04 Mapping causal genetic processes in non-Mendelian pediatric rare disease https://reporter.nih.gov/search/yXtO81BILEyW059FnTp9Gw/project-details/11145022 NIH mutation, stem cell, cell differentiation, chromatin organization, epigenetic biomarker 6
1R21ES035448-01A1 Understanding the role of bedrock, settlement patterns, and water quality in human health https://reporter.nih.gov/search/rPzAFQKclE-CWsCvmvDEWw/project-details/10888796 NIH cancer, neoplasm, malignancy obesity, risk factor 5
2RF1AG064227-06 O-GLCNAC Homeostasis Regulates Mitochondrial Function In Alzheimer’s Disease https://reporter.nih.gov/search/jbdyB9Ah4kKdhkogEi-MQg/project-details/11228244 NIH stem cell, signal transduction, transcriptional regulation, cell proliferation prevention 5
5P41EB020594-11 Biotechnology Resource Center of BioModular Multi-scale Systems (CBM2) for Precision Medicine: An Innovative Label-Free Dual-Nanopore TOF Sensor for Detection and Identification of Single Molecules https://reporter.nih.gov/search/79mIRXh520-c_C6K0WM1sA/project-details/11141031 NIH dna damage, signal transduction, epigenetic screening, biomarker 5
5R01GM130858-06  Control of Chromosome Segregation by DNA Topoisomerase II https://reporter.nih.gov/search/AYBxawPccEqxswLYc1f1yQ/project-details/11061074#similar-Projects NIH cancer, neoplasm, malignancy, signal transduction 5
5R35GM145240-04 Decoding the Assembly and Function of Paralogue Specific SIN3A and SIN3B Human Chromatin Remodeling Complexes and Networks https://reporter.nih.gov/search/k68UtKnG40CvJoX1HhGn8g/project-details/11330298#similar-Projects NIH cancer, carcinoma, mutation, chromatin organization, experimental therapeutics 5
5R01HD103161-05 Histone Demethylases and Trophoblast Differentiationt https://reporter.nih.gov/search/IIvxMI8BK0y5dJgQz_vdTg/project-details/11146572 NIH stem cell, transcriptional regulation, cell differentiation, epigenetic 4
5R01HD112559-02 Pathways Affecting Trophoblast Development https://reporter.nih.gov/search/BOrF4FgZ_kuIvVliUjEsCw/project-details/11114056 NIH stem cell, signal transduction, cell differentiation, chromatin organization 4
5R01HD113717-02 REST-MED12 Pathways in the Regulation of Estrogen - Progesterone Sensitivity in Uterine Leiomyoma https://reporter.nih.gov/search/PN_GfZUVlUScO_S9cm3nFQ/project-details/11049563#similar-Projects NIH tumor, mutation, cell differentiation, epigenetic 4
5R01NR021468-02 Addressing Malnutrition in Transplant and Cellular Therapy Patients with Healthcare-Food Bank Partnerships https://reporter.nih.gov/search/cSY5G85380eMdGXse4k5jg/project-details/11195727 NIH cancer, oncology, neoplasm, malignancy 4
NA Revealing LIM-Domain Transcriptional Complexes that Establish and Maintain Alpha-Cell Mass https://reporter.nih.gov/search/PN_GfZUVlUScO_S9cm3nFQ/project-details/11049563#similar-Projects NIH mutation, transcriptional regulation, cell differentiation obesity 4
1U24OD038400-01 Data Coordinating and Operations Center for the ECHO IDeA States Pediatric Clinical Trials Network https://reporter.nih.gov/search/Yx4ATYVRzE6fi77HMaAUqw/project-details/11146636#similar-Projects NIH rural 3
2UG1OD024943-08 Sunflower Pediatric Clinical Trials (SPeCTr 3.0) https://reporter.nih.gov/search/AWZghckn5ESLG-rN-FlddQ/project-details/11075553 NIH clinical trial phase i, obesity, rural 3
5P20GM130423-07 The Kansas Institute for Precision Medicine: Biomedical Engineering Core https://reporter.nih.gov/search/_A0UZF0gfk6_ZaYVzcqc3A/projects NIH neoplasm drug development, biomarker 3
5R01AI158368-04 Influence of Integrant-Derived HBV RNAs Encoding the Envelope Proteins on HBV Life Cycle https://reporter.nih.gov/search/gAIswd2V7UejLttwQahUrw/project-details/11012396 NIH cancer biomarker, hepatitis 3
5R01EB031579-04 mRNA Expression Profiling from Extracellular Vesicles (EVs): Generating a Rapid Diagnostic for Stroke https://reporter.nih.gov/search/iG5JpXKA-0WEnTVzAoYX4Q/project-details/11083697 NIH screening, prevention, biomarker 3
5U01AI183950-02 Sex Specific Differences in Intestinal Radiosensitivity https://reporter.nih.gov/search/ynVFjqFgN0Oib4-1fOvulw/project-details/11098596 NIH stem cell, radiation, cell proliferation 3
1R01AG087372-01A1 Analytical Tools for Light-Initiated Zn2+ Signaling in Neurodegenerative Disease https://reporter.nih.gov/search/cYylD_GHLEm0UCzZrIFing/project-details/11054363 NIH signal transduction drug development 2
5P20GM139733-03 Kansas Center for Implementation Science: Administrative Core https://reporter.nih.gov/search/H11jNoM5lkKgL_NGm8OUbQ/project-details/11180207#similar-Projects NIH prevention, rural 2
5P20GM139733-03 Kansas Center for Implementation Science: Pragmatic Implementation Science Methods (PrISM) Core https://reporter.nih.gov/search/nkth7Ql0I0q4cOKw4rt2lw/project-details/11180209#similar-Projects NIH cancer rural 2
5R00HD107158-04 A home-based intervention to improve adherence to the 24-Hour Movement Guidelines in young children https://reporter.nih.gov/search/e8_RCxRbP0qXW2MNAVsZ_Q/project-details/11088923 NIH obesity, exercise 2
5R01GM149665-02 Post-translational regulation of hepatic uptake transporters in health and disease https://reporter.nih.gov/search/_VY7xvBe5USI2Wwx6339ag/project-details/11130923 NIH obesity, drug delivery 2
5R33AG078087-04 Guided Episodic Future Thinking to Increase Physical Activity Adherence and Promote Healthy Brain Aging Among Mid-Life Adults https://reporter.nih.gov/search/I6ip7Tzmx0mj5bxm1v15eQ/project-details/11109430 NIH prevention, exercise 2
5U24DK128125-05 The Physiology of the Weight Reduced State Data Coordinating Center https://reporter.nih.gov/search/Xgq_SIdyikm8of-QChi9pA/project-details/11085269 NIH clinical trial phase i, obesity 2
5UL1TR002366-09 Frontiers Clinical and Translational Science Institute at the University of Kansas https://reporter.nih.gov/search/KJWIGjSRpkWURYy6VdFi-A/project-details/11170583 NIH clinical trial phase i, rural 2
7R01DK128132-04 A novel link between gene regulation and histone modifications governing islet beta-cell development and function https://reporter.nih.gov/search/lDVGOas8xkKyf2CXfEM_vA/project-details/11318696 NIH transcriptional regulation, epigenetic 2
1R35GM156876-01 Mechanisms of Metabolic Adaptation: from Single Molecules to Systems Biology https://reporter.nih.gov/search/rMfXLUussUipThxH6JQqew/project-details/11018713 NIH signal transduction 1
2R35GM138029-06 Determining mechanisms of innate immune modulation by ADP-ribosylation https://reporter.nih.gov/search/ZCO3-HdtAU-nCSA8uDJDaA/project-details/11095408 NIH transcriptional regulation 1
5P20GM130423-07 The Kansas Institute for Precision Medicine https://reporter.nih.gov/search/_A0UZF0gfk6_ZaYVzcqc3A/projects NIH biomarker 1
5P20GM130423-07 The Kansas Institute for Precision Medicine: Administrative Core https://reporter.nih.gov/search/_A0UZF0gfk6_ZaYVzcqc3A/projects NIH biomarker 1
5P20GM130423-07 The Kansas Institute for Precision Medicine: Biobanking and Biovalidation Core https://reporter.nih.gov/search/_A0UZF0gfk6_ZaYVzcqc3A/projects NIH biomarker 1
5P20GM130423-07 The Kansas Institute for Precision Medicine: Quantitative ’Omics Core https://reporter.nih.gov/search/_A0UZF0gfk6_ZaYVzcqc3A/projects NIH drug development 1
5R35GM151083-03 Glycoscience Tools and Therapeutics https://reporter.nih.gov/search/dsmFsRn56UaT2VGJ0MuYFw/project-details/11061035 NIH cell proliferation 1
5U01MD017700-05 The Effect of Medicaid Expansion on Mortality Disparities and Poverty https://reporter.nih.gov/search/65CAk-DCnUORfCMgkVfyLA/project-details/11146636 NIH rural 1
IK6BX005769-01 BLRD Research Career Scientist Award Application https://www.research.va.gov/about/funded_research/proj-details-FY2025.cfm?pid=727141 Other - Peer cancer, tumor, neoplasm, chemotherapy, metastatic, carcinoma, breast, mutation, p53, stem cell, immunotherapy, cell proliferation, cell differentiation, apoptosis, drug discovery clinical trial phase i, prevention, drug development, biomarker 19
IK6BX006529-01 BLRD Research Career Scientist Award Application https://www.research.va.gov/about/funded_research/proj-details-FY2025.cfm?pid=801652 Other - Peer carcinoma, cancer, tumor, colorectal, signal transduction, experimental therapeutics biomarker, risk factor 9
IK6BX006481-01 BLRD Research Career Scientist Award Application https://www.research.va.gov/about/funded_research/proj-details-FY2025.cfm?pid=787117 Other - Peer cancer, tumor, malignancy, metastatic, carcinoma, colorectal, experimental therapeutics drug development 8
I01BX002567-09 Ovarian function and hepatic mitochondrial quality control in steatosis https://www.research.va.gov/about/funded_research/proj-details-FY2025.cfm?pid=798779 Other - Peer signal transduction obesity, risk factor, exercise, cirrhosis 5
NU58DP007644 Communities leading change: Advancing Black and Latino capacity to create nutrition and physical activity environmental and systems change https://www.childrensmercy.org/childrens-mercy-research-institute/news-and-stories/dr-robin-shook-receives-cdc-funding-to-improve-health-prevent-chronic-disease-in-kansas-city/ Other - Peer cancer prevention, obesity, exercise 4
I01BX006060-01A2 Role of PTSD associated gut dysbiosis and barrier dysfunctions in promoting IBD in Veterans https://www.research.va.gov/about/funded_research/proj-details-FY2025.cfm?pid=772599 Other - Peer signal transduction risk factor 2
NU58DP007632 Racial and Ethnic Approaches to Community Health (REACH) https://www.cdc.gov/reach/media/pdfs/2025/01/REACH-2023-recipient-project-profiles-508.pdf#nameddest=Kansas and https://kumc.info/school-of-medicine/academics/departments/population-health/research/reach-for-health-and-wellbeing-in-southwest-kansas.html Other - Peer rural, exercise 2
MCB-2506282 EAGER: Tools4Cells: Tools for locus-specific and interaction-specific protein depletion https://ui.adsabs.harvard.edu/abs/2025nsf….2506282B/abstract Other - Peer chromatin organization 1
1013080_KUMC SWOG Network Group Operations Center of the NCTN https://reporter.nih.gov/search/xhL1ZeIiZke76AUeNdYKxQ/project-details/11251678#similar-Projects Other Non-Peer cancer, oncology, neoplasia, neoplasm, immunotherapy clinical trial phase i, clinical trial phase ii, clinical trial phase iii 8
N/A Ribonucleotide Processing in Telomere Maintenance and Integrity https://reporter.nih.gov/search/g4Bml0fNHkSr7cTS8XZEfg/project-details/11072066 Other Non-Peer cancer, carcinoma, dna damage, mutation, apoptosis risk factor 6
INV-076016 GCWHI: Improving Women’s Health through On-Line Education & Training https://gcgh.grandchallenges.org/grant/improving-womens-health-globally-through-line-education-and-training Other Non-Peer stem cell screening, prevention, risk factor, vaccine 5
23CDA1053102 ANKRD26 in Thrombocytopenia https://pubmed.ncbi.nlm.nih.gov/40170493/ Other Non-Peer malignancy, mutation biomarker 3
58-3093-5-007 Pecan polyphenol metabolites and offspring fatty liver disease https://www.ars.usda.gov/research/project/?accnNo=447773 Other Non-Peer obesity, cirrhosis 2
1 UU7TH54332-01-00 Technology-Enabled Learning Collaborative Program https://simpler.grants.gov/opportunity/b10d4b03-9e31-4578-b538-ec182a06936c Other Non-Peer rural 1
5K08CA279877-03 A Healthy Weight Intervention for Family Stress during the Early Phases of ALL Treatment: NOURISH-ALL https://reporter.nih.gov/search/yjGLmr72uUuJUCw_W8_w-Q/project-details/11163464 Training Grants cancer, neoplasm, leukemia, survivorship clinical trial phase i, prevention, obesity 7
5F31ES036459-02 Investigating XRCC1 coordination with DNA polymerase beta chromatin during BER https://reporter.nih.gov/search/uClAFVt9Nk2ZBhBl-k4kRg/project-details/11192212#similar-Projects Training Grants dna damage, dna repair, mutation, chromatin organization 4
5K08HL163471-04 Exploring the Mechanisms of Action of Anti-Adamts 13 Antibodies in Immune Thrombotic Thrombocytopenic Purpura https://reporter.nih.gov/search/AwkfOr5fHEuEUBmZ4qrZMw/project-details/11167569 Training Grants neoplasm, malignancy, lymphoma, immunotherapy 4
5T32HD069038-15 Children’s Mercy Hospital Collaborative Fellowship Program in Pediatric Pharmacology https://reporter.nih.gov/search/GOIB36Ttv0WVFv6j5BJoMQ/project-details/11118901 Training Grants oncology clinical trial phase i, drug development 3
5KL2TR002367-09 Institutional Career Development Core https://reporter.nih.gov/search/mohcAAqmE0C2sJ-C9QQPgQ/project-details/11164681 Training Grants obesity, exercise 2
5K12GM154719-02 IRACDA at the University of Kansas https://reporter.nih.gov/search/_iPSFRLm8kiAC3_Y7Mk8Ow/project-details/11138685 Training Grants cancer 1